FeesSafety
Pluang+

Luxxfolio partners with Greywick to tokenize Litecoin as cLTC on Canton Network, targeting late 2026 launch.

Protocol Fundamentals
02 Nov 2026, 01:56 WIB
Blockonomi
View Source
Bullish
Luxxfolio partners with Greywick to tokenize Litecoin as cLTC on Canton Network, targeting late 2026 launch.

Luxxfolio Holdings, a publicly listed Litecoin miner, signed a non-binding letter of intent with Greywick Digital to become the first ecosystem partner for cLTC, a tokenized Litecoin on the Canton Network. The partnership explores locking mined LTC in Greywick’s reserve to issue cLTC 1:1, enabling institutional market access without selling LTC on public exchanges. The mainnet launch is targeted for late 2026, pending technical and attestation details. This collaboration aims to expand Litecoin’s utility and provide new treasury management and financing options for institutional holders.

Luxxfolio's recent partnership with Greywick to explore institutional liquidity for cLTC is presented here with Pluang's cryptocurrency market data as of Nov 02, 2026 05:42 WIB. On that day, out of 50 major cryptocurrencies priced on Pluang, 16 rose and 33 fell. Notable movers include TRX (TRON) with a price of Rp5.728 and a 1-day change of +3.54%, GRT (The Graph) at Rp358 down 4.53%, and LINK (Chainlink) at Rp205.077 down 4.12%. The most notable figure is TRX's 87% buy order activity on Pluang.

More News

LUXEED's smart factory produces a vehicle every minute using AI and 880 robots for precision.

LUXEED's smart factory produces a vehicle every minute using AI and 880 robots for precision.

LUXEED showcased its Super Factory where over 2,000 intelligent devices and 880 robots work together to produce one vehicle every minute. The factory uses AI-driven automation for processes like welding and quality inspection, ensuring high precision...

Market News
Bullish
59 minutes ago
Anteris reports positive 30-day results for Medium-size DurAVR heart valve in severe aortic stenosis patients

Anteris reports positive 30-day results for Medium-size DurAVR heart valve in severe aortic stenosis patients

Anteris Technologies announced favorable 30-day clinical outcomes for its Medium-size DurAVR Transcatheter Heart Valve (THV) in 22 patients with severe aortic stenosis. The valve showed excellent hemodynamics with low pressure gradients, large effect...

Market News
Bullish
4 hours ago
Mesoblast announces board retirements and plans to add new commercial experts amid growth phase

Mesoblast announces board retirements and plans to add new commercial experts amid growth phase

Mesoblast Limited announced the retirement of two board members, William Burns after 12 years and Dr. Philip Krause since 2022, recognizing their significant contributions. The company, now a revenue-generating commercial enterprise following the FDA...

Company Fundamentals
Neutral
5 hours ago
CT-guided PCI matches IVUS outcomes with faster procedures and less contrast, changing treatment plans in 70% of cases.

CT-guided PCI matches IVUS outcomes with faster procedures and less contrast, changing treatment plans in 70% of cases.

A landmark P4 randomized trial showed that CT-guided percutaneous coronary intervention (PCI) delivers clinical outcomes comparable to the gold-standard intravascular ultrasound (IVUS) at one year, while reducing procedure time by 27% and contrast us...

Market News
Bullish
5 hours ago
THORChain halts trading on 10 blockchains after Ethereum reorg causes 10 ETH solvency shortfall

THORChain halts trading on 10 blockchains after Ethereum reorg causes 10 ETH solvency shortfall

THORChain paused trading across 10 blockchain networks after an Ethereum reorganization caused a vault to send 10 ETH without receiving the matching deposit, creating a solvency shortfall. The issue occurred when a 10 ETH deposit appeared in a block ...

Market News
Bearish
5 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App